Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture’s disease (anti-GBM). J Autoimmun. 2014;48–49:108–12.
Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033–42.
Article CAS PubMed Google Scholar
Available from: https://cdn.jsn.or.jp/jsn_new/iryou/free/kousei/pdf/53_4_509-555.pdf
Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int. 2016;89:897–908.
Chauveau B, Gibier J-B, Olagne J, Morel A, Aydin S, McAdoo SP, et al. Atypical anti-glomerular basement membrane nephritis: a case series from the French Nephropathology Group. Am J Kidney Dis. 2024;83:713-728.e1.
Article CAS PubMed Google Scholar
Bharati J, Yang Y, Sharma P, Jhaveri KD. Atypical anti-glomerular basement membrane disease. Kidney Int Rep. 2023;8:1151–61.
Article PubMed PubMed Central Google Scholar
Sporinova B, McRae SA, Muruve DA, Fritzler MJ, Nasr SH, Chin AC, et al. A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis. BMC Nephrol. 2019;20:29.
Article PubMed PubMed Central Google Scholar
Reggiani F, L’Imperio V, Calatroni M, Pagni F, Sinico RA. Goodpasture syndrome and anti-glomerular basement membrane disease. Clin Exp Rheumatol. 2023;41:964–74.
Ohlsson S, Herlitz H, Lundberg S, Selga D, Mölne J, Wieslander J, et al. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. Am J Kidney Dis. 2014;63:289–93.
Liu Z, Zou Y, Davidson A, Wiley. Plasma cells in systemic lupus erythematosus: the long and short of it all. Eur J Immunol. 2011. https://doi.org/10.1002/eji.201041354.
Article PubMed PubMed Central Google Scholar
Chang H-D, Tokoyoda K, Hoyer B, Alexander T, Khodadadi L, Mei H, et al. Pathogenic memory plasma cells in autoimmunity. Curr Opin Immunol. 2019;61:86–91.
Article CAS PubMed PubMed Central Google Scholar
Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med. 2004;199:1577–84.
Article CAS PubMed PubMed Central Google Scholar
Bolton WK. Goodpasture’s syndrome. Kidney Int. 1996;50:1753–66.
Article CAS PubMed Google Scholar
Flores JC, Savage COS, Lockwood CM, Taube D, Cameron JS, Williams DG, et al. Clinical and immunological evolution of oligoanuric anti-gbm nephritis treated by haemodialysis. Lancet. 1986;327:5–8.
Costedoat-Chalumeau N, Houssiau FA. Improving medication adherence in patients with lupus nephritis. Kidney Int. 2021;99:285–7.
Harry O, Crosby LE, Mara C, Ting TV, Huggins JL, Modi AC. Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus. Pediatr Rheumatol Online J. 2020;18:36.
Article PubMed PubMed Central Google Scholar
Emamikia S, Gomez A, Ådahl T, von Perner G, Enman Y, Chatzidionysiou K, et al. Factors associated with non-adherence to medications in systemic lupus erythematosus: results from a Swedish survey. Lupus. 2024;33:615–28.
Comments (0)